All Type of News
Yuhan to go global with gastritis drug Revanex
Yuhan Corporation has been most active with its homegrown gastric acid pump antagonist Revanex (revaprazan) in exploring a number of overseas markets, including 10 countries in South America.
Yuhan says it signed a...
Health ministry nervous over rumor
The rumor that gingko biloba preparations will be reclassified as drugs eligible for health insurance is still spreading, according to pharmaceutical sources.
In fact, the Health Insurance Review Agency (HIRA) is s...
Patent application of plant based anti-obesity medicines up sharply in 2007
The Korea Industrial Property Office says that the domestic patent application for anti-obesity drugs using natural products, such as plants, animals and minerals, filed in 2007 increased sharply from 1998.
The pat...
Release of Ciprobay and Aspirin Protects to be suspended for two months
Bayer Korea will suspend the supply of Ciprobay (ciprofloxacin) and Aspirin Protect to its associate wholesalers by the end of May, according to pharmaceutical business sources.
Bayer has requested wholesalers to p...
Oriental doctors challenge sales ban of placenta extract preparations
A dispute has arisen over the sales ban of placenta extract preparations derived from pigs or sheep.
Oriental doctors have threatened to sue the government, saying placenta extract preparations have been safely use...
Korea to face hospital pharmacists
Pharmacists working at hospitals nationwide are projected to be lower due to a labor shortage caused by the controversial six-year pharmacy college system.
Recently, the Ministry of Education, Science and Technolog...
GMP rating to be released
The Korea Food and Drug Administration plans to release the results of all drug manufacturer's GMP ratings on individual products within this month at the latest.
The KFDA said the GMP rating system may encourage p...
Green Cross launches sustained release vitamin C capsuleGreen Cross Corporation says it has launched C-mate SR, vitamin C sustained release capsule of which ingredient is imported from Eurand S.p.A of Italy.
According to GCC, the ...
|
DHP Korea and Dongwha enter agreement over Zabofloxacin
DHP Korea and Dongwha Pharmaceutical has recently announced an agreement granting DHP exclusive rights to develop and commercialize Zabofloxacin (DW224a) in the field of ophthalmology.
DHP plans to develop Zaboflox...
Choi receives management awardKwangdong Pharm Chairman Choi Soo-bu received a 2008 management award from the Daehan Association of Business Administration.
The management award has been given to business ...
|
